Patient Lifestyle

The 420 mg strength of Hercessi, a biosimilar to Herceptin, is used to treat HER2-overexpressing breast and gastric or gastroesophageal junction adenocarcinoma.

This program utilizes a machine-learning model to identify people who are likely to have elevated Lp(a).

Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome.

A collaboration with the Mayo Clinic, the center provides associates access to top cancer specialists.

Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis.

For the third year, CVS Pharmacy is offering more than 60 allergy-friendly treats in stores and online.

Thrifty White Health received the Innovation Award.

Aetna is offering a wide array of Medicare Advantage plan options, including $0 monthly plan premium and $0 primary care copay, among others.